MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
- 11 September 2003
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 22 (39), 8031-8041
- https://doi.org/10.1038/sj.onc.1206928
Abstract
Early-stage non-small cell lung cancer (NSCLC) can be cured by surgical resection, but a substantial fraction of patients ultimately dies due to distant metastasis. In this study, we used subtractive hybridization to identify gene expression differences in stage I NSCLC tumors that either did or did not metastasize in the course of disease. Individual clones (n=225) were sequenced and quantitative RT–PCR verified overexpression in metastasizing samples. Several of the identified genes (eIF4A1, thymosin 4 and a novel transcript named MALAT-1) were demonstrated to be significantly associated with metastasis in NSCLC patients (n=70). The genes' association with metastasis was stage- and histology specific. The Kaplan–Meier analyses identified MALAT-1 and thymosin 4 as prognostic parameters for patient survival in stage I NSCLC. The novel MALAT-1 transcript is a noncoding RNA of more than 8000 nt expressed from chromosome 11q13. It is highly expressed in lung, pancreas and other healthy organs as well as in NSCLC. MALAT-1 expressed sequences are conserved across several species indicating its potentially important function. Taken together, these data contribute to the identification of early-stage NSCLC patients that are at high risk to develop metastasis. The identification of MALAT-1 emphasizes the potential role of noncoding RNAs in human cancer.Keywords
This publication has 25 references indexed in Scilit:
- Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAsNature, 2002
- Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclassesProceedings of the National Academy of Sciences, 2001
- Genomic analysis of metastasis reveals an essential role for RhoCNature, 2000
- eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of TranslationAnnual Review of Biochemistry, 1999
- Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13Genes, Chromosomes and Cancer, 1998
- A Transcript Map for the 2.8-Mb Region Containing the Multiple Endocrine Neoplasia Type 1 LocusGenome Research, 1997
- Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinomaCytogenetic and Genome Research, 1997
- A novel method for real time quantitative RT-PCR.Genome Research, 1996
- A radiation hybrid map of 506 STS markers spanning human chromosome 11Nature Genetics, 1994
- Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancerThe Lancet, 1992